Published in Breast Cancer Res Treat on August 09, 2014
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers. BMC Med (2015) 0.84
Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer. Genome Biol (2015) 0.78
Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance. PLoS One (2016) 0.78
Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR(+), HER2(-) advanced breast cancer: results from BOLERO-2. Br J Cancer (2017) 0.77
The PI3K Pathway: Background and Treatment Approaches. Breast Care (Basel) (2016) 0.76
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers. Breast Cancer Res (2016) 0.75
Disease evolution and heterogeneity in bilateral breast cancer. Am J Cancer Res (2016) 0.75
Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients. Oncotarget (2017) 0.75
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ (2000) 5.64
Fine needle aspiration cytology, in relationships to clinical examination and mammography in the diagnosis of a solid breast mass. Br J Surg (1984) 3.30
Effect of antibiotic treatment on duration of excretion of Salmonella typhimurium by children. Br Med J (1965) 3.27
Alcohol and the emergency service patient. Br Med J (1980) 3.11
Detection and prevalence of pneumococci with increased resistance to penicillin. Can Med Assoc J (1977) 2.73
Use of enoxaparin results in more haemorrhagic complications after breast surgery than unfractionated heparin. Br J Surg (2008) 2.71
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol (2009) 2.65
The clinical significance of heterotopic pancreas in the gastrointestinal tract. Br J Surg (1981) 2.57
Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut (1983) 2.53
Treatment of elderly patients with breast cancer. BMJ (1992) 2.34
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Immediate reporting of fine needle aspiration of breast lesions. BMJ (1991) 2.29
Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin. J Infect Dis (1974) 2.18
Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol (1999) 2.13
Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin. Antimicrob Agents Chemother (1972) 2.13
Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer (2007) 2.07
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
Value of dilute inocula in cultural examination of sputum. Lancet (1965) 1.96
MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction. Cell (1998) 1.84
Removing bias in surgical trials. BMJ (1997) 1.84
ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics. BMJ (1994) 1.77
Isolation of mycobacteria from tonsils, naso-pharyngeal secretions and lymph nodes in East Anglia. Tubercle (1970) 1.68
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene (2006) 1.66
Mammary duct ectasia. Br J Surg (1983) 1.65
Raised intraocular pressure (IOP) and perioperative visual loss in laparoscopic colorectal surgery: a catastrophe waiting to happen? A systematic review of evidence from other surgical specialities. Tech Coloproctol (2012) 1.64
Oestrogen receptor concentration in primary breast cancer and axillary node metastases. Breast Cancer Res Treat (1981) 1.64
Fine-needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies. Cancer (1986) 1.64
Is abdominal wall tenderness a useful sign in the diagnosis of non-specific abdominal pain? Ann R Coll Surg Engl (1988) 1.63
Invasive cribriform carcinoma of the breast. Histopathology (1983) 1.53
Salmonellas of subgenus 3 (Arizona) isolated from abattoirs in England and Wales. J Hyg (Lond) (1966) 1.49
The closed eyes sign: an aid to diagnosing non-specific abdominal pain. BMJ (1988) 1.49
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging (2000) 1.47
Letter: Pneumococcus with increased resistance to penicillin. Lancet (1974) 1.43
Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg (1984) 1.43
The ethics of difficult tracheal intubation. Anaesthesia (1988) 1.41
Long-term survivors after breast cancer. Br J Surg (1985) 1.38
Breast reconstruction after mastectomy. Br J Surg (1995) 1.38
Asymptotic time dependence in the fractal pharmacokinetics of a two-compartment model. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 1.37
Complications associated with the wearing of contact lenses. JAMA (1966) 1.36
Wound compression pads are of no value after local anaesthetic breast biopsy. Ann R Coll Surg Engl (1991) 1.33
Primary lymphoma of the breast. Br J Surg (1987) 1.30
Fine needle aspiration of the breast: importance of the operator. Lancet (1983) 1.25
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer (2006) 1.24
Diagnostic delay in breast cancer. Br J Surg (2004) 1.24
ABC of breast diseases. Management of regional nodes in breast cancer. BMJ (1994) 1.23
The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study. Breast Cancer Res Treat (2010) 1.21
Varicocoele caused by a pancreatic pseudocyst. Gut (1983) 1.21
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol (2009) 1.19
Fine needle aspiration cytology, with immediate reporting, in the outpatient diagnosis of breast disease. Ann R Coll Surg Engl (1987) 1.18
Acute amiodarone-induced lung toxicity. Intensive Care Med (1998) 1.18
ABC of breast diseases. Breast cancer. BMJ (1994) 1.17
Surgery and radiotherapy for early breast cancer. BMJ (1995) 1.15
Diphtheria bacilli isolated in Alberta in 1967 from the throat, nose, ears and skin. Can Med Assoc J (1969) 1.15
Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. Eur J Surg Oncol (2003) 1.14
Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg (1994) 1.14
Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer (1994) 1.13
Experience with agar-filled plastic spoons for the transport of specimens of urine. Can Med Assoc J (1968) 1.13
Group A Streptococcus resistant to erythromycin and lincomycin. Can Med Assoc J (1968) 1.12
KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals. Oncogene (2012) 1.12
Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole. Br J Cancer (2006) 1.11
Two cases of Van Buchem's disease. J Neurol Neurosurg Psychiatry (1982) 1.11
Anisotropic elastic properties of microtubules. Eur Phys J E Soft Matter (2005) 1.11
Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae. J Clin Microbiol (1994) 1.11
The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease. Eur J Cancer Clin Oncol (1985) 1.10
Surgeons' views on multi-disciplinary breast meetings. Eur J Cancer (2006) 1.10
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. Br J Cancer (2010) 1.09
Follow-up after breast cancer. BMJ (2008) 1.09
Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer (2000) 1.08
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg (1987) 1.07
The magic nature of (132)Sn explored through the single-particle states of (133)Sn. Nature (2010) 1.07
Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int (2011) 1.07
Risk factors for breast cancer. BMJ (1995) 1.07
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood (1987) 1.07
Diphtheria in North America. J Hyg (Lond) (1984) 1.06
Does local surgery have a role in the management of stage IV breast cancer? Eur J Surg Oncol (2003) 1.05
ABC of breast diseases. Prognostic factors. BMJ (1994) 1.05
Periductal mastitis/duct ectasia. World J Surg (1990) 1.04
Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice. Ann Surg (1984) 1.04
Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. Eur J Cancer (2000) 1.04
Current status of cryptococcosis in Canada. Mycoses (1990) 1.03
TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer (2007) 1.03
ABC of breast diseases. Metastatic breast cancer. BMJ (1994) 1.03
Ionic wave propagation along actin filaments. Biophys J (2004) 1.01
Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol (1985) 0.99
Evaluation of an automated fluorescent treponemal antibody test for syphilis. Br J Vener Dis (1970) 0.98
The advantage of adrenaline in local and general anaesthetic breast biopsy. J R Coll Surg Edinb (1983) 0.98
Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh) (1982) 0.98
Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen. Eur J Cancer (2003) 0.97
The pharmacology of tri-potassium di-citrato bismuthate (TDB). Postgrad Med J (1975) 0.97
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. Clin Cancer Res (2000) 0.97
Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg (1995) 0.97
The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res Treat (1991) 0.97
Review of human and animal cases of coccidioidomycosis diagnosed in Canada. Mycopathologia (1991) 0.96
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. Br J Cancer (2009) 0.96
Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy. J Steroid Biochem Mol Biol (2001) 0.96
Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg (1983) 0.94